Clinical Trial Detail

NCT ID NCT03784326
Title Atezolizumab, Oxaliplatin, and Fluorouracil in Treating Patients With Esophageal or Gastroesophageal Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Atezolizumab + Fluorouracil + Oxaliplatin

Age Groups: adult senior

No variant requirements are available.